Haemonetics's market cap is currently $2.35B. The company's EPS TTM is $1.1; its P/E ratio is 14.90; Haemonetics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $1.11. See an overview of income statement, balance sheet, and cash flow financials.
